Chlorpromazine hydrochloride
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Chlorpromazine hydrochloride
- Generic name
- CHLORPROMAZINE HYDROCHLORIDE
- Manufacturer
- Zydus Lifesciences Limited
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 0ea5e0c6-0062-4be3-96f2-62397da3e77d
- SPL ID
- bea6994f-8f72-4c2d-8ba3-c74b10f8412d
- Version
- 4
- Effective date
- 2024-06-04
- Source export date
- 2026-10-12
- Source partition
- 5
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/13cbfcd236c665f0ee69e2d9141331148dcdff45d1679c92f029cfba27dd74a2/drug-label-0005-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 01:43:34
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 213368 | derived:openfda.application_number |
| application number | ANDA213368 | openfda.application_number | |
| brand name | Chlorpromazine hydrochloride | openfda.brand_name | |
| generic name | CHLORPROMAZINE HYDROCHLORIDE | openfda.generic_name | |
| manufacturer name | Zydus Lifesciences Limited | openfda.manufacturer_name | |
| ndc | package | 70771-1510-1 | openfda.package_ndc |
| ndc | package | 70771-1506-1 | openfda.package_ndc |
| ndc | package | 70771-1508-1 | openfda.package_ndc |
| ndc | package | 70771-1507-1 | openfda.package_ndc |
| ndc | package | 70771-1509-1 | openfda.package_ndc |
| ndc | package | 70771-1506-2 | openfda.package_ndc |
| ndc | package | 70771-1507-4 | openfda.package_ndc |
| ndc | package | 70771-1509-4 | openfda.package_ndc |
| ndc | package | 70771-1508-4 | openfda.package_ndc |
| ndc | package | 70771-1508-2 | openfda.package_ndc |
| ndc | package | 70771-1510-2 | openfda.package_ndc |
| ndc | package | 70771-1510-4 | openfda.package_ndc |
| ndc | package | 70771-1509-2 | openfda.package_ndc |
| ndc | package | 70771-1506-4 | openfda.package_ndc |
| ndc | package | 70771-1507-2 | openfda.package_ndc |
| ndc | product | 70771-1507 | openfda.product_ndc |
| ndc | product | 70771-1510 | openfda.product_ndc |
| ndc | product | 70771-1506 | openfda.product_ndc |
| ndc | product | 70771-1509 | openfda.product_ndc |
| ndc | product | 70771-1508 | openfda.product_ndc |
| ndc11 | package | 70771150804 | derived:openfda.package_ndc |
| ndc11 | package | 70771150702 | derived:openfda.package_ndc |
| ndc11 | package | 70771150802 | derived:openfda.package_ndc |
| ndc11 | package | 70771150704 | derived:openfda.package_ndc |
| ndc11 | package | 70771150904 | derived:openfda.package_ndc |
| ndc11 | package | 70771150801 | derived:openfda.package_ndc |
| ndc11 | package | 70771150602 | derived:openfda.package_ndc |
| ndc11 | package | 70771150901 | derived:openfda.package_ndc |
| ndc11 | package | 70771151001 | derived:openfda.package_ndc |
| ndc11 | package | 70771150701 | derived:openfda.package_ndc |
| ndc11 | package | 70771150604 | derived:openfda.package_ndc |
| ndc11 | package | 70771151004 | derived:openfda.package_ndc |
| ndc11 | package | 70771150902 | derived:openfda.package_ndc |
| ndc11 | package | 70771151002 | derived:openfda.package_ndc |
| ndc11 | package | 70771150601 | derived:openfda.package_ndc |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.